Viewpoints

This section provides a space for coalition members to share short pieces that provide an expert opinion or a perspective on an issue related to COVID-19 clinical research.

If you would like to join the coalition, fill this form.

Read the viewpoint guidelines to find out how to submit a viewpoint.

A conversation with Prof. Caesar Atuire about country ownership and pandemic response

7 November 20227 November 2022

We interviewed Prof. Caesar Atuire, a member of the Coalition’s Ethics Working Group, about “Country ownership in global health”, an opinion piece by Dr Abdisalan Mohamed Noor published earlier this year in PLOS Global Public Health. Prof. Atuire shared his perspective on Dr Noor’s lessons learned and their importance for a fairer, more global response to future pandemics.

We need context-specific evidence to inform public health pandemic strategies in low-resource settings: A consideration of lockdowns

1 December 20217 November 2022

Nearly two years into the COVID-19 pandemic, Dr Wilber Sabiiti, co-chair of the coalition's Virology, Immunology and Diagnostics Working Group, makes a case for the need to strengthen context-specific evidence generation to guide pandemic strategies. In this Viewpoint, he looks at diverging approaches in Uganda and Tanzania, in their use of national lockdowns.

A TRIPS waiver is urgently needed to make progress on COVID-19 vaccine equity

15 July 202121 July 2021

The coalition's Social Science Working Group and co-signatories have published a viewpoint on vaccine equity, arguing that a temporary TRIPS waiver is needed for COVID-19 vaccines and other medicines. Vaccine inequity is amongst the most significant social justice issues of our generation, and it poses a major threat to the global COVID-19 response. Urgent action is needed to improve equity and bring an end to the COVID-19 pandemic, including in low- and middle-income countries.